Benutzer: Gast  Login
Titel:

Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients' Perspectives.

Dokumenttyp:
Article; Journal Article; Research Support, Non-U.S. Gov't
Autor(en):
Willems, Laurent M; Rosenow, Felix; Schubert-Bast, Susanne; Kurlemann, Gerhard; Zöllner, Johann Philipp; Bast, Thomas; Bertsche, Astrid; Bettendorf, Ulrich; Ebrahimi-Fakhari, Daniel; Grau, Janina; Hahn, Andreas; Hartmann, Hans; Hertzberg, Christoph; Hornemann, Frauke; Immisch, Ilka; Jacobs, Julia; Klein, Karl Martin; Klotz, Kerstin A; Kluger, Gerhard; Knake, Susanne; Knuf, Markus; Marquard, Klaus; Mayer, Thomas; Meyer, Sascha; Muhle, Hiltrud; Müller-Schlüter, Karen; von Podewils, Felix; Ruf, Sus...     »
Abstract:
BACKGROUND: The approval of everolimus (EVE) for the treatment of angiomyolipoma (2013), subependymal giant cell astrocytoma (2013) and drug-refractory epilepsy (2017) in patients with tuberous sclerosis complex (TSC) represents the first disease-modifying treatment option available for this rare and complex genetic disorder. OBJECTIVE: The objective of this study was to analyse the use, efficacy, tolerability and treatment retention of EVE in patients with TSC in Germany from the patient's pers...     »
Zeitschriftentitel:
CNS Drugs
Jahr:
2021
Band / Volume:
35
Heft / Issue:
10
Seitenangaben Beitrag:
1107-1122
Volltext / DOI:
doi:10.1007/s40263-021-00839-4
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/34275102
Print-ISSN:
1172-7047
TUM Einrichtung:
Fachgebiet Nephrologie (Prof. Heemann)
 BibTeX